New Key Statistics Module, Z-Score and F-Score
OTCPK:PLSH Key Ratios
Market Cap $ M | 1.27 |
Enterprise Value $ M | 23.39 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 0.26 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | 4.00 |
EPS (TTM) $ | -0.35 |
Beneish M-Score | -3.69 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -5.24 |
EV-to-EBITDA | -8.16 |
PEG | -- |
Shares Outstanding M | 20.76 |
Net Margin (%) | -150.91 |
Operating Margin % | -108.58 |
Pre-tax Margin (%) | -150.91 |
Quick Ratio | 0.03 |
Current Ratio | 0.22 |
ROA % (ttm) | -35.69 |
ROE % (ttm) | -- |
ROIC % (ttm) | -16.25 |
Dividend Yield % | -- |
Altman Z-Score | -5.14 |
PLSH Number of Guru Trades
PLSH Volume of Guru Trades
Gurus Latest Trades with OTCPK:PLSH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:PLSH is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Panacea Life Sciences Holdings Inc Insider Transactions
No Available Data
News about OTCPK:PLSH
Total 0- 1